Mitra Biotech is a global leader in advancing personalized oncology treatment and supporting more effective and efficient cancer drug development. We are committed to developing industry transforming new technologies to bridge the knowledge gap within existing biomarker-guided strategies for cancer treatment, expanding access to truly personalized medicine, and significantly enhancing the clinical management of cancer. Our unique CANscript™ platform delivers powerful individualized treatment response predictions to inform patient-specific cancer treatment selection and enhance drug discovery.